AAAAAA

   
Results: 1-20 |
Results: 20
LONG-TERM SURVIVAL AND DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH ACLARUBICIN OR DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE FOLLOWED BY INTENSIVE CONSOLIDATION CHEMOTHERAPY IN A DANISH NATIONAL PHASE-III TRIAL
Authors: BROWN PD HOFFMANN T HANSEN OP BOESEN AM GRONBAEK K HIPPE E JENSEN MK THORLING K STORM HH PEDERSENBJERGAARD J
Citation: Pd. Brown et al., LONG-TERM SURVIVAL AND DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH ACLARUBICIN OR DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE FOLLOWED BY INTENSIVE CONSOLIDATION CHEMOTHERAPY IN A DANISH NATIONAL PHASE-III TRIAL, Leukemia, 11(1), 1997, pp. 37-41
CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA IN PATIENTS WITH THROMBOCYTOPENIA
Authors: KRISTENSEN J KILLANDER A HIPPE E HELLEBERG C ELLEGARD J HOLM M KUTTI J MELLQVIST UH JOHANSSON JE GLAZER S HEDNER U
Citation: J. Kristensen et al., CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA IN PATIENTS WITH THROMBOCYTOPENIA, Haemostasis, 26, 1996, pp. 159-164
A SEQUENTIAL ERYTHROPOIETIN AND GM-CSF SCHEDULE OFFERS CLINICAL BENEFITS IN THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES
Authors: BERNELL P STENKE L WALLVIK J HIPPE E HAST R
Citation: P. Bernell et al., A SEQUENTIAL ERYTHROPOIETIN AND GM-CSF SCHEDULE OFFERS CLINICAL BENEFITS IN THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES, Leukemia research, 20(8), 1996, pp. 693-699
MEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN MULTIPLE-MYELOMA
Authors: WISLOFF F EIKA S HIPPE E HJORTH M HOLMBERG E KAASA S PALVA I WESTIN J
Citation: F. Wisloff et al., MEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN MULTIPLE-MYELOMA, British Journal of Haematology, 92(3), 1996, pp. 604-613
INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL
Authors: HJORTH M WESTIN J DAHL IMS GIMSING P HIPPE E HOLMBERG E LAMVIK J NIELSEN JL LOFVENBERG E PALVA IP RODJER S TALSTAD I TURESSON I WISLOFF F ZADOR G AMSLERNORDIN S POLGARY M ODEN A WALLGREN A WILHELMSEN L HELLQVIST L HASSELBLOM S CARNESKOG J LINDQVIST O HOFFMAN P OLSSON K THOLEN A STOLT CM RINDNER A SVENSSON R VAART J HANSEN S ENGQVIST L LANNEMYR O NILSSON PG LINNE I LILJA G TALLROTH G HALLGREN J ANDERSSON B BILLSTROM R PERSSON S SAMUELSSON T ODEBERG H ADRIANSSON M TOVE H STOBEUS N HABBERSTAD J END T DAHLEN M ERIKSSON M ANAGRIUS N ARONSON D NEZADAL L ERIKSSON K HEDENUS M RYDE J WESTIN L ANDERSSON LO BJURMAN A FORSBERG K FORS D WIKSTROM S THULE B BOLSOY U LENNERMO K STRAND T PALVA I ALMQVIST A ISOMAA B OKSANEN K EIKA C LY B BRANDT E WEYDE K FOSSUM C LOVASEN K SPARBY JA JACOBSEN EM RINDE M NYHUS S KAHRS J STEEN T GRAVDAHL H BORGE L GROTTUM KA FLOTTEROD O STROM BR KNUTSEN H DRIVENES A PAULSEN J RIIS S HAUGE PW NESTHUS I COLL P HOLE KH SAETER T SINDRE T BERENTSEN S NES H VAGSTAD G HEIKKELA R SHAMMAS V LODEMEL B SKOGEN OR SORUM Y KVAMBE V BULL O JAEGER S INGVALDSEN PG PEDERSEN K HANSEN LT ONKIEHONG M HAUGNES T STEFANSEN D GADEBERG O ABILDGAARD N JANS H MOURITSANDERSEN T NEUBAUER B CLAUSEN NT MAGNUSSON S EYJOLFSSON G BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
COBALAMIN AND COBALAMIN-BINDING PROTEINS IN PLASMA RELATED TO THE CLINICAL CONDITION IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: GIMSING P OVERBALLEPETERSEN C HIPPE E
Citation: P. Gimsing et al., COBALAMIN AND COBALAMIN-BINDING PROTEINS IN PLASMA RELATED TO THE CLINICAL CONDITION IN CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 9(9), 1995, pp. 1604-1609
SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA
Authors: JULIUSSON G HELDAL D HIPPE E HEDENUS M MALM C WALLMAN K STOLT CM EVENSEN SA ALBERTIONI F TJONNFJORD G LENKEI R LILIEMARK J
Citation: G. Juliusson et al., SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA, Journal of clinical oncology, 13(4), 1995, pp. 989-995
THYROID-FUNCTION AND AUTOIMMUNITY IN PERNICIOUS-ANEMIA BEFORE AND DURING CYANOCOBALAMIN TREATMENT
Authors: OTTESEN M FELDTRASMUSSEN U ANDERSEN J HIPPE E SCHOUBOE A
Citation: M. Ottesen et al., THYROID-FUNCTION AND AUTOIMMUNITY IN PERNICIOUS-ANEMIA BEFORE AND DURING CYANOCOBALAMIN TREATMENT, Journal of endocrinological investigation, 18(2), 1995, pp. 91-97
COBALAMIN-DEPENDENT METABOLISM IN CHRONIC MYELOGENOUS LEUKEMIA DETERMINED BY DEOXYURIDINE SUPPRESSION TEST AND THE FORMIMINOGLUTAMIC ACID AND METHYLMALONATE EXCRETION IN URINE
Authors: GIMSING P HIPPE E
Citation: P. Gimsing et E. Hippe, COBALAMIN-DEPENDENT METABOLISM IN CHRONIC MYELOGENOUS LEUKEMIA DETERMINED BY DEOXYURIDINE SUPPRESSION TEST AND THE FORMIMINOGLUTAMIC ACID AND METHYLMALONATE EXCRETION IN URINE, American journal of hematology, 49(2), 1995, pp. 121-130
RENAL-FUNCTION IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - A DEMOGRAPHIC-STUDY OF 1353 PATIENTS
Authors: KNUDSEN LM HIPPE E HJORTH M HOLMBERG E WESTIN J
Citation: Lm. Knudsen et al., RENAL-FUNCTION IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - A DEMOGRAPHIC-STUDY OF 1353 PATIENTS, European journal of haematology, 53(4), 1994, pp. 207-212
SUCCESSFUL TREATMENT OF MYELODYSPLASTIC SYNDROME-ASSOCIATED ANEMIA WITH RHGM-CSF
Authors: HANSEN PB PRI TK HIPPE E
Citation: Pb. Hansen et al., SUCCESSFUL TREATMENT OF MYELODYSPLASTIC SYNDROME-ASSOCIATED ANEMIA WITH RHGM-CSF, La Presse medicale, 23(22), 1994, pp. 1042-1042
DIRECT AND QUANTITATIVE VITAMIN-B12 ABSORPTION MEASUREMENT IN PATIENTS WITH DISORDERS IN THE DISTAL PART OF THE BOWEL - COMPARISON OF THE STOOL SPOT-TEST [SST] WITH WHOLE-BODY COUNTING IN PATIENTS WITH ILEAL PELVIC RESERVOIR, ILEOSTOMY OR CROHNS-DISEASE
Authors: BAYAT M BRYNSKOV J DIGEPETERSEN H HIPPE E LONBORGJENSEN H
Citation: M. Bayat et al., DIRECT AND QUANTITATIVE VITAMIN-B12 ABSORPTION MEASUREMENT IN PATIENTS WITH DISORDERS IN THE DISTAL PART OF THE BOWEL - COMPARISON OF THE STOOL SPOT-TEST [SST] WITH WHOLE-BODY COUNTING IN PATIENTS WITH ILEAL PELVIC RESERVOIR, ILEOSTOMY OR CROHNS-DISEASE, International journal of colorectal disease, 9(2), 1994, pp. 68-72
SEQUENTIAL TREATMENT WITH ERYTHROPOIETIN AND GM-CSF IN ANEMIC PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: BERNELL P WALLVIK J STENKE L HIPPE E GRUBER A GRIMFORS G LOFVENBERG E HAST R
Citation: P. Bernell et al., SEQUENTIAL TREATMENT WITH ERYTHROPOIETIN AND GM-CSF IN ANEMIC PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 84(10), 1994, pp. 10000317-10000317
NEUROPEPTIDE-Y (NPY) AS A TUMOR-MARKER
Authors: PRIO TK HIPPE E CHRISTENSEN NJ
Citation: Tk. Prio et al., NEUROPEPTIDE-Y (NPY) AS A TUMOR-MARKER, European journal of haematology, 51(4), 1993, pp. 253-253
MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY
Authors: KELDSEN N BJERRUM OW DAHL IMS DRIVSHOLM A ELLEGAARD J GADEBERG O GIMSING P GRONVOLD T HANSEN MM HIPPE E LAMVIK J LY B SKARBOVIK A TALSTAD I THORLING K WESENBERG K WISLOFF F
Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85
RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS RECOMBINANT-HUMAN-ERYTHROPOIETIN MAY IMPROVE ANEMIA IN SELECTED PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HANSEN PB JOHNSEN HE HIPPE E HELLSTROMLINDBERG E RALFKIAER E
Citation: Pb. Hansen et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS RECOMBINANT-HUMAN-ERYTHROPOIETIN MAY IMPROVE ANEMIA IN SELECTED PATIENTS WITH MYELODYSPLASTIC SYNDROMES, American journal of hematology, 44(4), 1993, pp. 229-236
HYPEREOSINOPHILIC SYNDROME TREATED WITH ALPHA-INTERFERON AND GRANULOCYTE COLONY-STIMULATING FACTOR BUT COMPLICATED BY NEPHROTOXICITY
Authors: HANSEN PB JOHNSEN HE HIPPE E
Citation: Pb. Hansen et al., HYPEREOSINOPHILIC SYNDROME TREATED WITH ALPHA-INTERFERON AND GRANULOCYTE COLONY-STIMULATING FACTOR BUT COMPLICATED BY NEPHROTOXICITY, American journal of hematology, 43(1), 1993, pp. 66-68
DIURNAL-VARIATIONS OF SERUM ERYTHROPOIETIN IN TRAINED AND UNTRAINED SUBJECTS
Authors: KLAUSEN T DELA F HIPPE E GALBO H
Citation: T. Klausen et al., DIURNAL-VARIATIONS OF SERUM ERYTHROPOIETIN IN TRAINED AND UNTRAINED SUBJECTS, European journal of applied physiology and occupational physiology, 67(6), 1993, pp. 545-548
THE EFFECT OF SHORT AND LONG-DURATION EXERCISE ON SERUM ERYTHROPOIETIN CONCENTRATIONS
Authors: KLAUSEN T BREUM L FOGHANDERSEN N BENNETT P HIPPE E
Citation: T. Klausen et al., THE EFFECT OF SHORT AND LONG-DURATION EXERCISE ON SERUM ERYTHROPOIETIN CONCENTRATIONS, European journal of applied physiology and occupational physiology, 67(3), 1993, pp. 213-217
RECOMBINANT FACTOR-VIIA (RFVIIA) REDUCES THE BLEEDING-TIME IN PATIENTS WITH THROMBOCYTOPENIA
Authors: KRISTENSEN J KILLANDER A HIPPE E ELLEGAARD J HEDNER U
Citation: J. Kristensen et al., RECOMBINANT FACTOR-VIIA (RFVIIA) REDUCES THE BLEEDING-TIME IN PATIENTS WITH THROMBOCYTOPENIA, Blood, 82(10), 1993, pp. 10000155-10000155
Risultati: 1-20 |